Form D · Pharmaceuticals
Raptor Pharmaceutical Corp
Novato, CA · CIK 0001070698
Offering snapshot reported Aug 18, 2010 · SEC filing
- Reported sold
- $15.1M Offering amount: $15.1M
- Investors reported
- 24 Form D · investor count
- Minimum accepted
- $26.8K Reported outside-investor minimum
- First sale
- Aug 9, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 18, 2010 | Initial | $15,060,163 | No comparison | 24 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $979K
- Form D file number
- 021-146606
A warrant to purchase 97,952 shares of common stock par value $0.001 at an exercise price of $3.075.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| JMP Securities LLC | 22208 |
Source: Form D, filed Aug 18, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Raymond W. Anderson | Director |
| Thomas E. Daley | Executive |
| Richard L. Franklin | Director |
| Llew Keltner | Director |
| Patrice P. Rioux | Executive |
| Erich Sager | Director |
| Christopher M. Starr | Director, Executive |
| Kim R. Tsuchimoto | Executive |
| Todd C. Zankel | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
9 Commercial Blvd Suite 200
Novato, CA, 94949
Novato, CA, 94949